The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

(2013) John J Bissler et al.   LANCET

Tuberous sclerosis complex-associated kidney angiomyolipoma: from contemplation to action

(2013) Y. Pirson   NEPHROLOGY DIALYSIS TRANSPLANTATION

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

(2012) David Neal Franz et al.   LANCET

Tuberous Sclerosis Complex: Neurological, Renal and Pulmonary Manifestations

(2011) D. N. Franz et al.   NEUROPEDIATRICS

Tuberous sclerosis complex: tumors and tumorigenesis

(2010) Julita Borkowska et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis

(2010) Darcy A. Krueger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated

(2009) Prasanna Sooriakumaran et al.   BJU INTERNATIONAL

A case of tuberous sclerosis complex that progressed to end-stage renal disease

(2009) Mohammad Sarraf et al.   Nature Reviews Nephrology

Tuberous sclerosis

(2008) Paolo Curatolo et al.   LANCET